Brief: Evolus Reports First Quarter 2023 Results And Provides Business Update
May 9 (Reuters) - Evolus Inc EOLS.O :
* EVOLUS REPORTS FIRST QUARTER 2023 RESULTS AND PROVIDES
BUSINESS
UPDATE
* EVOLUS INC - RAISES 2028 REVENUE OUTLOOK FROM $500 MILLION
TO
$700 MILLION DRIVEN BY ADDITION OF EVOLYSSE™ DERMAL FILLER LINE
REPRESENTING A 29% CAGR
Source text for Eikon: ID:nBw7KTn7ka
Further company coverage: EOLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe